Fireside Chat: Unlocking the Next Frontier of Cell Therapy

Fireside Chat: Unlocking the Next Frontier of Cell Therapy

Tuesday, June 2, 2026 3:50 PM to 4:10 PM · 20 min. (America/New_York)
Main Stage
Track 2 - R&D Excellence – Biologics
Bio-ManufacturingClinical Development and ManufacturingDrug Formulation and DevelopmentM&A and Investment TrendsMarket InsightsR&D ExcellenceRegulation & Policy

Information

This session explores the expanding frontiers of cell therapy, moving beyond oncology into autoimmune and other complex diseases, while addressing critical CMC challenges and growing investment interest in in vivo approaches. Attendees will gain forward-looking perspectives on scalable manufacturing solutions, regulatory considerations, and strategic innovation required to broaden patient access and deliver transformative impact across multiple therapeutic areas.

Pfizer Inc.910At Pfizer CentreOne we help maximize your product's potential and reach patients faster. As a reliable extension of your network, we provide premium commercial manufacturing for your oral solids, sterile injectables and biologic drug products. You gain direct access to Pfizer's network of global sites, and benefit from our cutting-edge process optimization, scalable commercial manufacturing solutions and secure supply chains. Powered by Pfizer, we spent decades earning an uncompromising reputation for quality that we'll dedicate to the lightspeed delivery of your project.

Registered attendees

Danielle Hotten
Danielle Hotten
Director of Business Development
KH
Kristen Heslin
Global Priority Accounts DirectorUS Pharmacopeia (USP)
Mike Martin
Mike Martin
President & CEOISPE

Log in

See all the content and easy-to-use features by logging in or registering!